Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2023
Detecting isolated cognitive relapses in persons with MSSarah A Morrow, Zachary L Weinstock, Omid Mirmosayyeb, et al.
JAMA Neurology|September 3, 2014
The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosisJeffrey A Cohen, Arun V Krishnan, Andrew D Goodman, et al.
Journal of Neurology|June 3, 2026
Progressive disability but survival advantage in anti-Hu/ANNA1 paraneoplastic neurological syndromesKimberly A DiMauro, Nicolas R Thompson, Brittany Lapin, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
First-dose effects of fingolimod: Pooled safety data from three phase 3 studiesJohn P DiMarco, Paul O'Connor, Jeffrey A Cohen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
Long-term prognostic value of longitudinal measurements of blood neurofilament levelsDieter A Häring, Harald Kropshofer, Ludwig Kappos, et al.
Neurology|February 19, 2016
The challenge of comorbidity in clinical trials for multiple sclerosisRuth Ann Marrie, Aaron Miller, Maria Pia Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2023
Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extensionStephen L Hauser, Ronald Zielman, Ayan Das Gupta, et al.
Immunotherapy|May 31, 2012
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosisJeffery J Auletta, Amelia M Bartholomew, Richard T Maziarz, et al.
Expert Review of Neurotherapeutics|June 20, 2019
Developing therapeutic strategies to promote myelin repair in multiple sclerosisLaura E Baldassari, Jenny Feng, Benjamin L L Clayton, et al.
Pageof 23